HK1251449A1 - 用於治療2型糖尿病的交聯聚二烯丙基胺共聚物 - Google Patents
用於治療2型糖尿病的交聯聚二烯丙基胺共聚物Info
- Publication number
- HK1251449A1 HK1251449A1 HK18104883.2A HK18104883A HK1251449A1 HK 1251449 A1 HK1251449 A1 HK 1251449A1 HK 18104883 A HK18104883 A HK 18104883A HK 1251449 A1 HK1251449 A1 HK 1251449A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- polydiallymine
- diabetes
- crosslinked
- copolymers
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F299/00—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
- C08F226/04—Diallylamine
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/08—Epoxidation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
- C08K5/0025—Crosslinking or vulcanising agents; including accelerators
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/15—Heterocyclic compounds having oxygen in the ring
- C08K5/151—Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
- C08K5/1515—Three-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F26/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F26/02—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
- C08F26/04—Diallylamine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Epoxy Resins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462093751P | 2014-12-18 | 2014-12-18 | |
PCT/US2015/066006 WO2016100456A2 (en) | 2014-12-18 | 2015-12-16 | Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1251449A1 true HK1251449A1 (zh) | 2019-02-01 |
Family
ID=55221501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18104883.2A HK1251449A1 (zh) | 2014-12-18 | 2018-04-16 | 用於治療2型糖尿病的交聯聚二烯丙基胺共聚物 |
Country Status (27)
Country | Link |
---|---|
US (1) | US11267924B2 (zh) |
EP (1) | EP3233090A2 (zh) |
JP (2) | JP6866293B2 (zh) |
KR (1) | KR20170096008A (zh) |
CN (1) | CN107250189A (zh) |
AR (1) | AR103175A1 (zh) |
AU (1) | AU2015362590A1 (zh) |
BR (1) | BR112017012794A2 (zh) |
CA (1) | CA2971204A1 (zh) |
CL (1) | CL2017001579A1 (zh) |
CO (1) | CO2017007119A2 (zh) |
CR (1) | CR20170323A (zh) |
DO (1) | DOP2017000140A (zh) |
EA (1) | EA201791380A1 (zh) |
EC (1) | ECSP17045972A (zh) |
GT (1) | GT201700133A (zh) |
HK (1) | HK1251449A1 (zh) |
IL (1) | IL252899A0 (zh) |
MA (2) | MA41202A (zh) |
MX (1) | MX2017007966A (zh) |
PE (1) | PE20171510A1 (zh) |
PH (1) | PH12017501120A1 (zh) |
SG (1) | SG11201704840RA (zh) |
TN (1) | TN2017000253A1 (zh) |
TW (1) | TW201636030A (zh) |
UY (1) | UY36457A (zh) |
WO (1) | WO2016100456A2 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10479865B2 (en) * | 2017-11-01 | 2019-11-19 | Strides Shasun Limited | Process for the preparation of sevelamer carbonate |
WO2021024075A1 (en) * | 2019-08-07 | 2021-02-11 | 3M Innovative Properties Company | Articles containing a crosslinked guanidinyl-containing polymer and uses thereof |
AU2021431510A1 (en) * | 2021-03-01 | 2023-09-28 | Tricida, Inc. | Crosslinked poly(allylamine) polymer pharmaceutical compositions |
Family Cites Families (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2456428A (en) | 1944-10-11 | 1948-12-14 | Shell Dev | Polyallyl amine and related polymeric amines |
BE580490A (fr) | 1958-07-15 | 1960-01-08 | Merck & Co Inc | Compositions et procédés pour abaisser la teneur en cholestérol du sang |
US3104205A (en) | 1959-12-17 | 1963-09-17 | Warner Lambert Pharmaceutical | Deodorant composition comprising the copper complex of the copolymer of allylamine and methacrylic acid |
US3308020A (en) | 1961-09-22 | 1967-03-07 | Merck & Co Inc | Compositions and method for binding bile acids in vivo including hypocholesteremics |
US3332841A (en) | 1961-10-04 | 1967-07-25 | Lilly Co Eli | Method of treating hyperacidity |
BE640616A (zh) | 1962-12-19 | |||
US3293195A (en) | 1963-11-29 | 1966-12-20 | Ritter Pfaudler Corp | Ion exchange resins prepared from a mixed resin of vinyl pyridine copolymers and epihalohydrins-polyalkylene polyamines and methods of making and using same |
US3624209A (en) | 1966-12-28 | 1971-11-30 | Bristol Myers Co | Composition for treatment of gastro-intestinal disorders |
US3492397A (en) | 1967-04-07 | 1970-01-27 | Warner Lambert Pharmaceutical | Sustained release dosage in the pellet form and process thereof |
US4060598A (en) | 1967-06-28 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Tablets coated with aqueous resin dispersions |
DE1927336A1 (de) | 1968-06-17 | 1969-12-18 | Upjohn Co | Orale Dosierungsform zur Bekaempfung von Hypercholesterinaemie |
US3538214A (en) | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
US3980770A (en) | 1971-06-04 | 1976-09-14 | Pharmacia Aktiebolag | Polymerization products containing amino groups useful in serum cholesterol level control |
CH604722A5 (zh) | 1973-02-09 | 1978-09-15 | Sandoz Ag | |
US4205064A (en) | 1973-06-11 | 1980-05-27 | Merck & Co., Inc. | Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides] |
AR206115A1 (es) | 1973-06-11 | 1976-06-30 | Merck & Co Inc | Procedimiento para preparar un polimero lineal no ramificado y no reticulado |
US4016209A (en) | 1975-04-23 | 1977-04-05 | Merck & Co., Inc. | 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof |
US4181718A (en) | 1975-12-29 | 1980-01-01 | Mason Norbert S | Polyanion-stabilized aluminum hydrogels |
US4071478A (en) | 1976-06-07 | 1978-01-31 | Merck & Co., Inc. | Controlled partially cross-linked 3,3-ionenes |
US4183918A (en) | 1977-03-08 | 1980-01-15 | Exxon Research & Engineering Co. | Detoxifying-medicinal emulsions |
GB1573487A (en) | 1977-05-23 | 1980-08-28 | Bristol Myers Co | Bile acid binding composition |
US4143130A (en) | 1977-08-29 | 1979-03-06 | Warren-Teed Laboratories, Inc. | Method for treating kidney stones |
US4368725A (en) | 1977-11-11 | 1983-01-18 | Mcclintock Michael | Solar energy collector |
US4173626A (en) | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
US4247393A (en) | 1979-01-11 | 1981-01-27 | Wallace Richard A | Hemodialysis assist device |
US4439419A (en) | 1980-02-20 | 1984-03-27 | The Upjohn Company | Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin |
US4344993A (en) | 1980-09-02 | 1982-08-17 | The Dow Chemical Company | Perfluorocarbon-polymeric coatings having low critical surface tensions |
EP0055048B1 (en) | 1980-12-12 | 1985-04-03 | Smith and Nephew Associated Companies p.l.c. | Polymers, preparation and use |
US4504640A (en) | 1982-05-19 | 1985-03-12 | Nitto Boseki Co., Ltd. | Process for producing monoallylamine polymer |
JPS6090243A (ja) | 1983-10-25 | 1985-05-21 | Nitto Boseki Co Ltd | 小球状モノアリルアミン橋かけ重合体の製造方法 |
OA08092A (fr) | 1984-05-11 | 1987-03-31 | Bristol Myers Co | Novel bile sequestrant resin and uses. |
US4631305A (en) | 1985-03-22 | 1986-12-23 | The Upjohn Company | Polymeric material as a disintegrant in a compressed tablet |
DE3541511A1 (de) | 1985-11-19 | 1987-05-21 | Grace W R Ab | Promoter fuer die papierleimung, verfahren zu dessen herstellung und dessen verwendung |
AU628389B2 (en) | 1988-08-26 | 1992-09-17 | Pharmacia & Upjohn Company | Fine-beaded colestipol hydrochloride |
GB8829835D0 (en) | 1988-12-21 | 1989-02-15 | Smith Kline French Lab | Compounds |
DE3901527A1 (de) | 1989-01-20 | 1990-07-26 | Hoechst Ag | Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate |
US6274713B1 (en) | 1989-04-07 | 2001-08-14 | Salutar, Inc. | Polychelants |
US5236701A (en) | 1989-07-19 | 1993-08-17 | Lowchol Scientific Inc. | Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol |
US5136032A (en) | 1989-12-07 | 1992-08-04 | Daicel Chemical Industries, Ltd. | Method for separating phosphopolyol compounds using a separating agent |
US5053423A (en) | 1990-03-22 | 1991-10-01 | Quadra Logic Technologies Inc. | Compositions for photodynamic therapy |
JPH0687974B2 (ja) | 1990-03-27 | 1994-11-09 | 忠一 平山 | 発熱物質の吸着材料 |
DE4010271A1 (de) | 1990-03-30 | 1991-10-02 | Basf Ag | Verfahren zur herstellung von ethylenpolymerisaten bei druecken oberhalb von 500 bar in einem rohrreaktor mit einspritzfinger |
IE914179A1 (en) | 1990-12-07 | 1992-06-17 | Ici Plc | Nitrogen derivatives |
RU1808015C (ru) | 1990-12-27 | 1993-04-07 | Владимир Андреевич Шевченко | Способ защиты млекопитающих от воздействи гамма-излучени |
US5055197A (en) | 1991-04-05 | 1991-10-08 | Rohm And Haas Company | Process for removing residual monomers and oligemers from amine-containing polymers |
US5108767A (en) | 1991-06-10 | 1992-04-28 | Abbott Laboratories | Liquid nutritional product for persons receiving renal dialysis |
RU2108090C1 (ru) | 1991-07-03 | 1998-04-10 | Дзе Апджон Компани | Таблетка, содержащая гидрохлорид колестипола, и способ ее получения |
EP0534304A1 (de) | 1991-09-21 | 1993-03-31 | Hoechst Aktiengesellschaft | Cycloalkylierte Polyethyleniminderivate und ihre Verwendung als Hypolipidämika |
SE470006B (sv) | 1991-09-26 | 1993-10-25 | Corline Systems Ab | Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet |
EP0580079B1 (de) | 1992-07-22 | 1996-12-11 | Hoechst Aktiengesellschaft | Vernetzte, stickstoffhaltige Vinylcopolymere, Verfahren zu ihrer Herstellung sowie die Verwendung dieser Verbindungen |
EP0580078B1 (de) | 1992-07-22 | 1997-10-15 | Hoechst Aktiengesellschaft | Hydrophile Zentren aufweisende Polyvinylamin-Derivate, Verfahren zu ihrer Herstellung sowie die Verwendung der Verbindungen als Arzneimittel, Wirkstoffträger und Nahrungsmittelhilfsstoff |
EP0656029B1 (en) | 1992-08-20 | 1998-07-22 | E.I. Du Pont De Nemours And Company | Crosslinked polymeric ammonium salts |
US5302531A (en) | 1992-10-22 | 1994-04-12 | Miles Inc. | Composition for the semiquantitative determination of specific gravity of a test sample |
DE69330595T2 (de) | 1992-11-25 | 2002-05-23 | Ajinomoto Co., Inc. | Zubereitungen und Nahrungsmittel enthaltend Mineralien und Poly-gamma-Glutaminsäure |
DE69410995T2 (de) | 1993-02-17 | 1998-11-05 | British Technology Group Ltd., London | 1 guanidino gruppen enthaltende polymere zur verwendung in der therapie |
US5487888A (en) | 1993-05-20 | 1996-01-30 | Geltex, Inc. | Iron-binding polymers for oral administration |
WO1994027620A1 (en) | 1993-06-02 | 1994-12-08 | Geltex Pharmaceuticals, Inc. | Compositions and process for removing bile salts |
US5667775A (en) | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
US5496545A (en) | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
JPH0788181A (ja) * | 1993-09-21 | 1995-04-04 | Mitsubishi Rayon Co Ltd | エンドトキシン吸着材及び製法 |
US5414068A (en) | 1994-01-24 | 1995-05-09 | Rohm And Haas Company | Crosslinked anion exchange particles and method for producing the particles |
WO1996021454A1 (en) | 1995-01-12 | 1996-07-18 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
GB9503061D0 (en) | 1995-02-16 | 1995-04-05 | British Tech Group | Polymeric compounds |
JP2936129B2 (ja) | 1995-04-12 | 1999-08-23 | セイコー精機株式会社 | 防食構造 |
FI104823B (fi) | 1996-06-24 | 2000-04-14 | Borealis Polymers Oy | Likaantumista estävä päällyste |
TW592727B (en) | 1997-04-04 | 2004-06-21 | Chugai Pharmaceutical Co Ltd | Phosphate-binding polymer preparations |
JP3389493B2 (ja) | 1997-04-04 | 2003-03-24 | 中外製薬株式会社 | リン酸結合性ポリマー製剤 |
US6083497A (en) * | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
US6566407B2 (en) | 1997-11-05 | 2003-05-20 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
US5985938A (en) | 1997-11-05 | 1999-11-16 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
DE19835467A1 (de) | 1998-08-06 | 2000-02-17 | Elenac Gmbh | Feststoffreaktor mit antistatischer Beschichtung zur Durchführung von Reaktionen in der Gasphase |
TW568788B (en) | 1998-10-12 | 2004-01-01 | Chugai Pharmaceutical Co Ltd | Polymer combining with phosphoric acid and preparation containing the same |
US6500527B2 (en) | 2001-02-01 | 2002-12-31 | 3M Innovative Properties Company | Image receptor sheet |
CA2444046C (en) * | 2001-04-18 | 2011-06-07 | Steven K. Burke | Use of colesevelam in reducing serum glucose |
ITMI20021718A1 (it) | 2002-07-31 | 2004-02-01 | Sematic Italia Spa | Interruttore di sicurezza con sistema elettronico programmabile. |
AU2004311849B2 (en) | 2003-12-31 | 2009-04-02 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
EP1559419A1 (en) * | 2004-01-23 | 2005-08-03 | Fournier Laboratories Ireland Limited | Pharmaceutical formulations comprising metformin and a fibrate, and processes for their obtention |
US20060024368A1 (en) | 2004-07-30 | 2006-02-02 | Reza Fassihi | Compressed composite delivery system for release-rate modulation of bioactives |
EP1810689A4 (en) * | 2004-10-15 | 2009-07-22 | Mitsubishi Tanabe Pharma Corp | MEANS FOR THE PREVENTION AND / OR TREATMENT OF DIABETES |
US20060177415A1 (en) | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
EP2016947A1 (en) * | 2007-07-17 | 2009-01-21 | Chemo Ibérica, S.A. | Novel one step process for preparing cross-linked poly(allylamine) polymers |
PA8807201A1 (es) * | 2007-12-14 | 2009-07-23 | Genzyme Corp | Composiciones farmaceuticas |
WO2011106542A2 (en) | 2010-02-24 | 2011-09-01 | Relypsa, Inc. | Crosslinked polyvrnylamine, poly all ylamine, and polyethyleneimine for use as bile acid sequestrants |
DE112011100657T5 (de) | 2010-02-24 | 2013-02-28 | Relypsa, Inc. | Amin-polymere zur verwendung als gallensäuresequestriermittel |
CN106478948B (zh) | 2010-02-24 | 2019-05-07 | 瑞立普萨公司 | 用作胆汁酸螯合剂的聚咪唑 |
US20130156720A1 (en) * | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
EA201591733A1 (ru) * | 2013-03-15 | 2016-01-29 | Джензим Корпорейшн | Секвестранты предшественников конечного продукта усиленного гликозилирования (age) |
-
2015
- 2015-12-15 MA MA041202A patent/MA41202A/fr unknown
- 2015-12-16 CA CA2971204A patent/CA2971204A1/en not_active Abandoned
- 2015-12-16 TW TW104142366A patent/TW201636030A/zh unknown
- 2015-12-16 SG SG11201704840RA patent/SG11201704840RA/en unknown
- 2015-12-16 CN CN201580076247.4A patent/CN107250189A/zh active Pending
- 2015-12-16 MA MA40697A patent/MA40697A1/fr unknown
- 2015-12-16 AU AU2015362590A patent/AU2015362590A1/en not_active Abandoned
- 2015-12-16 PE PE2017001082A patent/PE20171510A1/es unknown
- 2015-12-16 EP EP15828422.4A patent/EP3233090A2/en not_active Withdrawn
- 2015-12-16 WO PCT/US2015/066006 patent/WO2016100456A2/en active Application Filing
- 2015-12-16 KR KR1020177019820A patent/KR20170096008A/ko active Search and Examination
- 2015-12-16 EA EA201791380A patent/EA201791380A1/ru unknown
- 2015-12-16 TN TN2017000253A patent/TN2017000253A1/en unknown
- 2015-12-16 CR CR20170323A patent/CR20170323A/es unknown
- 2015-12-16 US US14/971,424 patent/US11267924B2/en active Active
- 2015-12-16 MX MX2017007966A patent/MX2017007966A/es unknown
- 2015-12-16 BR BR112017012794A patent/BR112017012794A2/pt not_active Application Discontinuation
- 2015-12-16 JP JP2017532699A patent/JP6866293B2/ja active Active
- 2015-12-18 UY UY0001036457A patent/UY36457A/es not_active Application Discontinuation
- 2015-12-18 AR ARP150104195A patent/AR103175A1/es unknown
-
2017
- 2017-06-14 DO DO2017000140A patent/DOP2017000140A/es unknown
- 2017-06-14 IL IL252899A patent/IL252899A0/en unknown
- 2017-06-15 PH PH12017501120A patent/PH12017501120A1/en unknown
- 2017-06-16 GT GT201700133A patent/GT201700133A/es unknown
- 2017-06-16 CL CL2017001579A patent/CL2017001579A1/es unknown
- 2017-07-17 CO CONC2017/0007119A patent/CO2017007119A2/es unknown
- 2017-07-17 EC ECIEPI201745972A patent/ECSP17045972A/es unknown
-
2018
- 2018-04-16 HK HK18104883.2A patent/HK1251449A1/zh unknown
-
2020
- 2020-12-25 JP JP2020215991A patent/JP2021063229A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US11267924B2 (en) | 2022-03-08 |
EA201791380A1 (ru) | 2018-03-30 |
BR112017012794A2 (pt) | 2018-01-02 |
WO2016100456A2 (en) | 2016-06-23 |
IL252899A0 (en) | 2017-08-31 |
MX2017007966A (es) | 2018-03-15 |
ECSP17045972A (es) | 2017-11-30 |
KR20170096008A (ko) | 2017-08-23 |
PE20171510A1 (es) | 2017-10-20 |
UY36457A (es) | 2016-07-29 |
DOP2017000140A (es) | 2017-07-31 |
JP2018501358A (ja) | 2018-01-18 |
SG11201704840RA (en) | 2017-07-28 |
MA41202A (fr) | 2017-10-24 |
CA2971204A1 (en) | 2016-06-23 |
CR20170323A (es) | 2017-08-22 |
CO2017007119A2 (es) | 2017-08-18 |
CN107250189A (zh) | 2017-10-13 |
JP6866293B2 (ja) | 2021-05-12 |
MA40697A1 (fr) | 2018-01-31 |
TN2017000253A1 (en) | 2018-10-19 |
GT201700133A (es) | 2019-09-17 |
AR103175A1 (es) | 2017-04-19 |
EP3233090A2 (en) | 2017-10-25 |
WO2016100456A3 (en) | 2016-08-18 |
US20160177019A1 (en) | 2016-06-23 |
CL2017001579A1 (es) | 2018-03-23 |
JP2021063229A (ja) | 2021-04-22 |
AU2015362590A1 (en) | 2017-08-03 |
PH12017501120A1 (en) | 2018-01-08 |
TW201636030A (zh) | 2016-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3332717A4 (en) | TREATMENT DEVICE | |
IL275482A (en) | Asketamine for the treatment of depression | |
GB201608885D0 (en) | Treatment | |
GB201502137D0 (en) | Treatment | |
GB201522243D0 (en) | Treatment | |
EP3056599A4 (en) | Clothing treatment device | |
EP3362091A4 (en) | COMBINATION THERAPY | |
GB201612165D0 (en) | Combinations for the treatment of type 2 diabetes | |
PL3145511T3 (pl) | Kompozycja do leczenia oka | |
GB201519450D0 (en) | Novel treatment | |
HK1251449A1 (zh) | 用於治療2型糖尿病的交聯聚二烯丙基胺共聚物 | |
EP3305975A4 (en) | Clothing treatment device | |
GB201508841D0 (en) | Treatment | |
PL3484475T3 (pl) | 1-Metylonikotynamid do leczenia choroby układu krążenia | |
EP3145525A4 (en) | Use of microperoxidases for the treatment of carboxyhemoglobinemia | |
GB201620323D0 (en) | Treatment Device | |
GB201411027D0 (en) | Treatment | |
EP3323368A4 (en) | TREATMENT TOOL | |
GB201503008D0 (en) | Treatment | |
GB201418541D0 (en) | Materials for use with general hyperthermia treatment | |
GB201412411D0 (en) | Treatment | |
GB201718985D0 (en) | Treatment | |
GB201713650D0 (en) | Treatment | |
GB201706955D0 (en) | Treatment | |
GB201711677D0 (en) | Combination treatment |